用于诊断血管特异性冠状动脉缺血的定量冠状动脉CT血管成像模型的开发与验证
本研究基于CREDENCE和PACIFIC-1研究的事后分析,开发并验证了人工智能引导的定量冠状动脉CT血管成像模型(AI-QCTISCHEMIA),该模型整合动脉粥样硬化与血管形态学指标。在CREDENCE验证队列中,AI-QCTISCHEMIA诊断冠状动脉缺血(FFR≤0.80)的AUC为0.80,优于FFRCT的0.69和MPI的0.65(P均<0.001)。在PACIFIC-1中,AI-QCTISCHEMIA阳性与MACE风险升高相关(aHR 7.6,95%CI 1.2-47.0,P=0.030)。
要点
- AI-QCTISCHEMIA模型基于冠状动脉CTA图像定量整合粥样硬化与血管形态特征,用于诊断FFR≤0.80的血管特异性缺血。
- 在CREDENCE验证队列中,AI-QCTISCHEMIA的AUC为0.80,高于FFRCT的0.69和MPI的0.65。
- 在PACIFIC-1中,校正临床危险因素和CTA阻塞性狭窄后,AI-QCTISCHEMIA阳性与MACE风险升高相关(aHR 7.6)。
核心结论
- 新开发的基于冠状动脉CTA的缺血模型利用冠状动脉粥样硬化和血管形态特征,能准确诊断有创FFR定义的冠状动脉缺血,并在狭窄存在之外提供对MACE的稳健预后效用。
研究设计与样本
- CREDENCE和PACIFIC-1研究的事后分析;AI-QCTISCHEMIA模型在CREDENCE开发队列中建立,在CREDENCE验证队列(n=305,年龄64.4±9.8岁,210[69%]男性)和PACIFIC-1(n=208,年龄58.1±8.7岁,132[63%]男性)中评估诊断性能;预后价值在PACIFIC-1中研究;参考标准为有创冠状动脉造影联合有创FFR测量(缺血定义为FFR≤0.80)。
诊断标准与关键数值
- CREDENCE验证队列中,AI-QCTISCHEMIA诊断冠状动脉缺血(FFR≤0.80)的患者水平AUC为0.80(95%CI 0.75-0.85),FFRCT为0.69(95%CI 0.63-0.74;P<0.001),MPI为0.65(95%CI 0.59-0.71;P<0.001)。
- PACIFIC-1中,AI-QCTISCHEMIA的AUC为0.85(95%CI 0.79-0.91),FFRCT为0.78(95%CI 0.72-0.84;P=0.037),PET为0.89(95%CI 0.84-0.93;P=0.262),SPECT为0.72(95%CI 0.67-0.78;P<0.001)。
临床应用与阅片要点
- AI-QCTISCHEMIA模型基于冠状动脉CTA图像定量整合粥样硬化与血管形态特征,用于诊断有创FFR≤0.80定义的血管特异性冠状动脉缺血。
- 在PACIFIC-1中,校正临床危险因素和冠状动脉CTA确定的阻塞性狭窄后,AI-QCTISCHEMIA阳性与MACE风险升高相关(aHR 7.6,95%CI 1.2-47.0;P=0.030)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Noninvasive stress testing is commonly used for detection of coronary ischemia but possesses variable accuracy and may result in excessive health care costs.
OBJECTIVES: This study aimed to derive and validate an artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT) model for the diagnosis of coronary ischemia that integrates atherosclerosis and vascular morphology measures (AI-QCTISCHEMIA) and to evaluate its prognostic utility for major adverse cardiovascular events (MACE).
METHODS: A post hoc analysis of the CREDENCE (Computed Tomographic Evaluation of Atherosclerotic Determinants of Myocardial Ischemia) and PACIFIC-1 (Comparison of Coronary Computed Tomography Angiography, Single Photon Emission Computed Tomography [SPECT], Positron Emission Tomography [PET], and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve) studies was performed. In both studies, symptomatic patients with suspected stable coronary artery disease had prospectively undergone coronary computed tomography angiography (CTA), myocardial perfusion imaging (MPI), SPECT, or PET, fractional flow reserve by CT (FFRCT), and invasive coronary angiography in conjunction with invasive FFR measurements. The AI-QCTISCHEMIA model was developed in the derivation cohort of the CREDENCE study, and its diagnostic performance for coronary ischemia (FFR ≤0.80) was evaluated in the CREDENCE validation cohort and PACIFIC-1. Its prognostic value was investigated in PACIFIC-1.
RESULTS: In CREDENCE validation (n = 305, age 64.4 ± 9.8 years, 210 [69%] male), the diagnostic performance by area under the receiver-operating characteristics curve (AUC) on per-patient level was 0.80 (95% CI: 0.75-0.85) for AI-QCTISCHEMIA, 0.69 (95% CI: 0.63-0.74; P < 0.001) for FFRCT, and 0.65 (95% CI: 0.59-0.71; P < 0.001) for MPI. In PACIFIC-1 (n = 208, age 58.1 ± 8.7 years, 132 [63%] male), the AUCs were 0.85 (95% CI: 0.79-0.91) for AI-QCTISCHEMIA, 0.78 (95% CI: 0.72-0.84; P = 0.037) for FFRCT, 0.89 (95% CI: 0.84-0.93; P = 0.262) for PET, and 0.72 (95% CI: 0.67-0.78; P < 0.001) for SPECT. Adjusted for clinical risk factors and coronary CTA-determined obstructive stenosis, a positive AI-QCTISCHEMIA test was associated with aHR: 7.6 (95% CI: 1.2-47.0; P = 0.030) for MACE.
CONCLUSIONS: This newly developed coronary CTA-based ischemia model using coronary atherosclerosis and vascular morphology characteristics accurately diagnoses coronary ischemia by invasive FFR and provides robust prognostic utility for MACE beyond presence of stenosis.
引用
- Nurmohamed NS, Danad I, Jukema RA, et al. Development and Validation of a Quantitative Coronary CT Angiography Model for Diagnosis of Vessel-Specific Coronary Ischemia. JACC Cardiovasc Imaging. 2024. PMID: 38483420. doi:10.1016/j.jcmg.2024.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。